Management
If the patient has a known allergen or trigger for the eosinophilic bronchitis, the recommended treatment is to avoid the triggers. If the cause of the eosinophilic bronchitis is unknown, the first line treatment is inhaled corticosteroids. Patients respond well to inhaled corticosteroids and their eosinophil counts in their sputum usually decrease after treatment.There has not been a study to determine the ideal dosage of inhaled corticosteroids for patients with eosinophilic bronchitis, and there is no consensus on whether the treatment should be discontinued once the patients symptoms resolve or to continue long-term. The use of oral corticosteroids for eosinophilic bronchitis is rare, but it may be considered when inhaled corticosteroids are ineffective in managing the symptoms. Epidemiology
Approximately 10–30% of people who present with a chronic cough are suspected to be symptomatic due to eosinophilic bronchitis. == References ==
Tricuspid valve stenosis is a valvular heart disease that narrows the opening of the hearts tricuspid valve. It is a relatively rare condition that causes stenosis (increased restriction of blood flow through the valve). Cause
Causes of tricuspid valve stenosis are:
Rheumatic disease
Carcinoid syndrome
Pacemaker leads (complication)

Diagnosis
A mild diastolic murmur can be heard during auscultation caused by the blood flow through the stenotic valve. It is best heard over the left sternal border with rumbling character and tricuspid opening snap with wide-splitting S2. The diagnosis will typically be confirmed by an echocardiograph, which will also allow the physician to assess its severity. Treatment
Tricuspid valve stenosis itself usually does not require treatment. If stenosis is mild, monitoring the condition closely suffices. However, severe stenosis, or damage to other valves in the heart, may require surgical repair or replacement. The treatment is usually by surgery (tricuspid valve replacement) or percutaneous balloon valvuloplasty. The resultant tricuspid regurgitation from percutaneous treatment is better tolerated than the insufficiency occurring during mitral valvuloplasty. See also
Echocardiography
Tricuspid valve

References


== External links ==